NCT00251576View on ClinicalTrials.gov

Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)

PHASE3CompletedINTERVENTIONAL

Enrollment

4,497

Participants

Timeline

Start Date

November 1, 1999

Primary Completion Date

March 23, 2004

Study Completion Date

March 23, 2004

Conditions

Acute Coronary Syndrome

Interventions

DRUG

A-Phase: tirofiban; Z-Phase simvastatin

DRUG

Duration of Treatment: A-Phase: minimum suggested 48 hours, maximum suggested 108 hours. Z-Phase: 2 years

DRUG

Comparator: A-Phase: low molecular weight heparin, unfractionated heparin

DRUG

Duration of Treatment: A-Phase: low molecular weight heparin, 2 to 8 days; unfractionated heparin, minium suggested 48 hours, maximum 108 hours

DRUG

Duration of Treatment: Z-Phase, 2 years.

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00251576 - Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180) | Biotech Hunter | Biotech Hunter